"The Investigators Are Comparing Lidocaine and Papaverine Nerve Blocks to Determine Which Improves Blood Flow Better, Making the Phoenix Sign Clearer on Imaging. This Helps Accurately Diagnose Nerve Compression, Improving Patient Care"

NACompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

March 7, 2024

Primary Completion Date

March 7, 2024

Study Completion Date

July 1, 2024

Conditions
Drop Foot
Interventions
DRUG

Infiltration of papaverine

The study was randomized and double blinded. For randomization, the first extremity had either an infiltration of 0.5 cc of papaverine HCL (30mg/ml) for a 15mg perineural infiltration, or .5 cc of 1% lidocaine without epinephrine determined by a coin toss application.

DRUG

Lidocaine infiltration

The study was randomized and double blinded. For randomization, the first extremity had either an infiltration of 0.5 cc of papaverine HCL (30mg/ml) for a 15mg perineural infiltration, or .5 cc of 1% lidocaine without epinephrine determined by a coin toss application.

Trial Locations (1)

47546

Indiana Foot and Ankle, Jasper

All Listed Sponsors
lead

US Neuropathy Centers

OTHER

NCT06919289 - "The Investigators Are Comparing Lidocaine and Papaverine Nerve Blocks to Determine Which Improves Blood Flow Better, Making the Phoenix Sign Clearer on Imaging. This Helps Accurately Diagnose Nerve Compression, Improving Patient Care" | Biotech Hunter | Biotech Hunter